Adma Biologics (ADMA) Change in Accured Expenses (2011 - 2025)
Adma Biologics (ADMA) posted Change in Accured Expenses of -$395000.0 for Q4 2025, down 68.8% on a QoQ basis from -$234000.0 in Q3 2025, and down 244.69% year-over-year from $273000.0 in Q4 2024.
Adma Biologics (ADMA) Change in Accured Expenses (2011 - 2025) Analysis & Trends
Adma Biologics' Change in Accured Expenses history runs 13 years deep, the most recent figure standing at -$395000.0 for Q4 2025.
- Quarterly Change in Accured Expenses fell 244.69% year-over-year to -$395000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.2 million (down 269.79% YoY) and the FY2025 annual result came in at -$1.2 million, down 269.79% from the prior year.
- Change in Accured Expenses was -$395000.0 for Q4 2025 at Adma Biologics, down from -$234000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $6.1 million in Q2 2023 and bottomed at -$5.9 million in Q2 2024.
- A 5-year average of -$79000.0 and a median of -$32992.0 in 2021 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses plunged 5213.88% — and 2024, when it surged 4081.48%.
- Adma Biologics' Change in Accured Expenses stood at -$5.3 million in 2021, then jumped by 97.43% to -$136585.0 in 2022, then tumbled by 4046.14% to -$5.7 million in 2023, then surged by 104.82% to $273000.0 in 2024, then sank by 244.69% to -$395000.0 in 2025.
- Business Quant data shows ADMA's Change in Accured Expenses at -$395000.0 in Q4 2025, -$234000.0 in Q3 2025, and $48000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | -395,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -395,000.00 |
| Dec 31, 2025 | -395,000.00 |
| Sep 30, 2025 | -234,000.00 |
| Sep 30, 2025 | -234,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | -650,000.00 |
| Mar 31, 2025 | -650,000.00 |
| Dec 31, 2024 | 273,000.00 |
| Dec 31, 2024 | 273,000.00 |
| Sep 30, 2024 | 5.65 Mn |
| Sep 30, 2024 | 5.65 Mn |
| Jun 30, 2024 | -5.87 Mn |
| Jun 30, 2024 | -5.87 Mn |
| Mar 31, 2024 | 677,000.00 |
| Mar 31, 2024 | 677,000.00 |
| Dec 31, 2023 | -5.66 Mn |
| Dec 31, 2023 | -5.66 Mn |
| Sep 30, 2023 | 135,000.00 |
| Sep 30, 2023 | 135,000.00 |